Mangoceuticals, Inc. (MGRX) vs NeuroSense Therapeutics Ltd. (NRSN)
A side-by-side comparison of Mangoceuticals, Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGRX
Mangoceuticals, Inc.
$0.41HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
NRSN
NeuroSense Therapeutics Ltd.
$3.91HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
Total return — MGRX vs NRSN
growth of $100 · dividends reinvested · last 4yMGRX -99.3% (-71.1%/yr)NRSN -88.4% (-41.6%/yr)NRSN compounded faster over this window
Log scale — wide-divergence pair
MGRX NRSN
MGRX vs NRSN: by the numbers
- •MGRX is the larger company ($7M vs $7M market cap).
- •Both run net losses; NRSN's is the smaller (0.00% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | MGRX | NRSN |
|---|---|---|
| P/S ratio | 22.21 | N/A |
| P/B ratio | 0.56 | N/A |
Profitability
| Metric | MGRX | NRSN |
|---|---|---|
| Gross margin | 54.43% | 0.00% |
| Operating margin | -4200.46% | 0.00% |
| Net margin | -4791.48% | 0.00% |
| ROE | -120.58% | N/A |
| ROIC | -102.91% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.